Evidence map›Paper›PMID 38361121›Full record

ArticleNature medicine2024

Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis.

Stefano Alivernini, Juan D Cañete, Jaume Bacardit, Mariola Kurowska-Stolarska

Open access · greenAbstract readLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. An interpretable multi-instance learning method for accurate differentiation of malignant and benign laryngeal lesions in laryngoscopy.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Stefano AliverniniImmunology Research Core Facility, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. stefano.alivernini@policlinicogemelli.it.
Juan D CañeteRheumatology Department, Hospital Clinic and FCRB-IDIBAPS, Barcelona, Spain.ORCID 0000-0003-2606-0573
Jaume BacarditInterdisciplinary Computing and Complex BioSystems (ICOS) Research Group, School of Computing, Newcastle University, Newcastle, UK.ORCID 0000-0002-2692-7205
Mariola Kurowska-StolarskaResearch into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, Glasgow, UK. Mariola.kurowska-stolarska@glasgow.ac.uk.ORCID 0000-0003-2124-7777
Arthritis UK · GBFundació Clínic per a la Recerca Biomèdica · ESNewcastle University · GBUniversità Cattolica del Sacro Cuore · IT

Funding

Medical Research Council MR/V036998/1Versus Arthritis 19213Versus Arthritis 22272
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidArtificial IntelligenceHumansAntirheumatic Agents

Identifiers

PMID38361121
OpenAlexW4391843349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.